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ABSTRACT Insulin stimulates glucose transport in muscle and adipose tissue by translocation 
of glucose transporter 4 (GLUT4) to the plasma membrane. We previously reported that ac-
tivation of the small GTPase RalA downstream of PI 3-kinase plays a critical role in this process 
by mobilizing the exocyst complex for GLUT4 vesicle targeting in adipocytes. Here we report 
the identifi cation and characterization of a Ral GAP complex (RGC) that mediates the activa-
tion of RalA downstream of the PI 3-kinase/Akt pathway. The complex is composed of an 
RGC1 regulatory subunit and an RGC2 catalytic subunit (previously identifi ed as AS250) that 
directly stimulates the guanosine triphosphate hydrolysis of RalA. Knockdown of RGC pro-
teins leads to increased RalA activity and glucose uptake in adipocytes. Insulin inhibits the 
GAP complex through Akt2-catalyzed phosphorylation of RGC2 in vitro and in vivo, while 
activated Akt relieves the inhibitory effect of RGC proteins on RalA activity. The RGC complex 
thus connects PI 3-kinase/Akt activity to the transport machineries responsible for GLUT4 
translocation.
INTRODUCTION
Insulin-stimulated glucose transport plays a key role in the mainte-
nance of glucose homeostasis (Saltiel and Kahn, 2001; Watson et al., 
2004). The hormone increases glucose uptake into insulin-responsive 
tissues including muscle and fat by recruitment of the facilitative 
glucose transporter 4 (GLUT4) from intracellular storage vesicles to 
the plasma membrane (Watson et al., 2004; Huang and Czech, 
2007). While our understanding of the precise mechanisms underly-
ing this process remains incomplete, it is clear that the translocation 
of GLUT4 vesicles requires concerted actions of distinct transport 
machineries that are governed by multiple signaling cascades 
(Watson and Pessin, 2006; Hou and Pessin, 2007). Activation of the 
protein kinase Akt downstream of PI 3-kinase plays a central role in 
the traffi cking of GLUT4 to the plasma membrane (Whiteman et al., 
2002; Hou and Pessin, 2007; Sakamoto and Holman, 2008), al-
though the exact mechanisms by which Akt signals cellular machin-
eries involved in the transport process remain to be elucidated.
One possible target of the PI 3-kinase/Akt pathway is the family 
of small GTPases (Watson and Pessin, 2006; Welsh et al., 2006; 
Ishikura et al., 2007), which act as “molecular switches” that operate 
at the crossroads of signaling and vesicle traffi cking (Bourne et al., 
1991; Takai et al., 2001; Grosshans et al., 2006). Once activated, 
these G proteins can mobilize transport machineries that facilitate 
specifi c steps in exocytosis, including vesicle budding, transport 
along cytoskeletal tracks, and tethering and docking at the plasma 
membrane (Ferro-Novick and Novick, 1993; Hall, 1998; Cai et al., 
2007). A number of small GTPases, including Ras, Rho, and Rab 
family members, have been implicated in insulin-stimulated GLUT4 
traffi cking (Welsh et al., 2006; Hou and Pessin, 2007; Ishikura et al., 
2008). We recently reported that activation of the small GTPase 
RalA by insulin plays an important role in plasma membrane target-
ing of GLUT4 vesicles through recognition of the exocyst (Chen 
et al., 2007), an evolutionarily conserved vesicle tethering complex 
(Novick and Guo, 2002; Schekman and Novick, 2004). RalA also in-
teracts with the molecular motor Myo1c complex that facilitates re-
cruitment of GLUT4 vesicles to the plasma membrane (Bose et al., 
2002; Chen et al., 2007). However, the exact mechanism by which 
insulin activates RalA remains to be established.
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The activation status of small GTPases is determined by specifi c 
guanine nucleotide exchange factors (GEFs) and GTPase-activating 
proteins (GAPs) (McCormick, 1998; Bos et al., 2007). In many sce-
narios, rather than simply terminating the activity of their cognate 
GTPase substrates, GAPs act as the primary determinants of GTPase 
activity based on upstream inputs (Kwiatkowski and Manning, 2005; 
Watson and Pessin, 2006). One example is the TSC1/2 complex, a 
tumor suppressor complex that functions as a GAP for the 
Rheb GTPase and serves as the primary mechanism whereby Rheb 
is activated (Manning and Cantley, 2003). This GAP complex is 
directly phosphorylated by Akt, in the process reducing its activity 
and thus relieving its inhibitory effect on Rheb GTPases, leading to 
activation of its downstream target, the mTORC1 kinase (Garami et 
al., 2003; Inoki et al., 2003; Patel et al., 2003; Saucedo et al., 2003; 
Stocker et al., 2003; Tee et al., 2003; Zhang et al., 2003). Likewise, it 
is thought that phosphorylation of the GAP AS160/TBC1D4 by Akt 
inhibits its activity toward Rab target proteins involved in insulin-
stimulated GLUT4 exocytosis (Sano et al., 2003, 2007; Miinea et al., 
2005). AS160 is thought to inactivate Rabs 8, 10, and/or 14 (Ishikura 
et al., 2007; Sano et al., 2007, 2008); however, the downstream 
machineries mobilized by these proteins have not yet been deter-
mined. Although the exact mechanism by which Akt inhibits TSC2 
and AS160 GAP activities remains unknown, these fi ndings point to 
a regulatory paradigm in which GAPs integrate signals from Akt to 
activate small GTPases, which in turn en-
gage with downstream effectors (Inoki and 
Guan, 2006; Huang and Manning, 2009). 
Here we report the identifi cation and char-
acterization of a Ral GAP complex (RGC) that 
connects the PI 3-kinase/Akt pathway to the 
activation of RalA, a small GTPase that 
mobilizes the exocyst complex to facilitate 
traffi cking of GLUT4 vesicles.
RESULTS
Identifi cation of the RGC in adipocytes
Previous studies have demonstrated that 
GAPs preferentially interact with their tar-
get GTPases during the transition state of 
guanosine triphosphate (GTP) hydrolysis 
(Bos et al., 2007; Scheffzek et al., 1997). 
This interaction is transient and occurs with 
lower affi nity when wild-type GTPases are 
locked in either guanosine diphosphate 
(GDP)– or GTP-bound states. However, 
binding of GTPases to GDP in complex 
with aluminum fl uoride (GDP/AlFx) mimics 
the GTP hydrolysis transition state, thus 
permitting stabilized GTPase–GAP inter-
action (Scheffzek et al., 1997; Wittinghofer, 
1997; see Figure 1A). We took advantage 
of this property in a proteomic approach 
to search for potential GAPs that may in-
teract with immobilized Ral loaded with 
GDP/AlFx in 3T3-L1 adipocytes since wild-
type RalA displayed a much lower GTP 
loading profi le than did its mutant form 
that fails to catalyze GTP hydrolysis in 
these cells (Supplemental Figure S1). Inter-
estingly, several proteins were found to 
preferentially associate with glutathione S-
transferase (GST)–RalA loaded with GDP/
AlFx but not with GDP-loaded GST-RalA or GST alone, and the 
most prominent of these proteins migrated at ∼200 kDa (p200; 
Figure 1B). When subjected to tandem mass spectrometry, four 
unique peptides were recovered with the protein; each sequence 
matched that of a protein named AS250 (Figure 1B). AS250, or 
Akt substrate of 250 kDa, was originally identifi ed as a phosphop-
rotein of 1984 amino acids that was purifi ed from adipocytes by 
virtue of its interaction with a phospho-Akt substrate antibody 
(Gridley et al., 2006). The protein contains a putative GAP domain 
homologous to TSC2 and RapGAP and was found to associate 
with the protein KIAA1219 (Gridley et al., 2006). In agreement 
with the mass spectrometry data, Western blotting (WB) revealed 
that p200 GAP (AS250) and its associating protein KIAA1219 spe-
cifi cally interacted with RalA bound to GDP/AlFx, but not with 
RalA bound to GDP or GTPγS, or GST alone (Figure 1C). Mean-
while, subunits of the exocyst proteins preferentially interacted 
with RalA loaded with GTPγS (Figure 1C), further confi rming the 
specifi city of the transition state–dependent binding between 
KIAA1219/p200 GAP and RalA that is characteristic of a GAP–
substrate GTPase interaction. We thus named these two proteins 
RGC1 and RGC2, to refl ect their function and homology with 
TSC1/2, as will be further described. RGC1 represents the regula-
tory subunit of the complex, while RGC2 contains the GAP domain 
and represents the catalytic subunit of the complex. 
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FIGURE 1: RGC2/AS250 preferentially interacts with RalA in the transition state. (A) Schematic 
view of the transition state interaction between GAPs and their cognate small GTPase targets. 
Top: GAPs interact preferentially with their cognate targets during the transition state of GTP 
hydrolysis. Bottom: Transition state of GTP hydrolysis mimicked by GDP in complex with 
aluminum fl uoride (AlFx). (B) 3T3-L1 adipocyte lysates were incubated with immobilized GST 
alone, GST-RalA bound to GDP, or GST-RalA bound to GDP/AlFx. Associated proteins were 
separated using 6% SDS–PAGE and visualized by silver staining; protein bands were cut from 
the gel and subjected to tandem mass spectrometry analysis. (C) Cell lysates from a 10-cm plate 
of 3T3-L1 adipocytes were incubated with 5 μg of immobilized GST or GST-RalA bound to GDP, 
GTPγS, or GDP/AlFx. Associated proteins were resolved on SDS–PAGE and visualized by WB 
using the indicated antibodies.
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RalA activity (Supplemental Figure S2). When immunoprecipitat-
ed from cell lysates of 3T3-L1 adipocytes by an anti-RGC2 anti-
body, RGC proteins effi ciently enhanced GTP hydrolysis of re-
combinant RalA in vitro, compared with RalA alone or RalA 
incubated with various control immunoprecipitates (Figure 2C). 
The immunoprecipitated RGC proteins also catalyzed GTP hydro-
lysis of the Ral family member RalB (Figure S3A). These results are 
in contrast to a previous report that failed to detect RGC GAP 
activity toward RalA or other G proteins (Gridley et al., 2006), 
We sought to explore the importance of the RGC in the regu-
lation of Ral activity by insulin. Consistent with the characteristic 
GAP–substrate GTPase interaction, siRNA-mediated depletion of 
the GAP RGC2 in 3T3-L1 adipocytes led to increased RalA activ-
ity in both the basal and insulin-stimulated states, as determined 
by a pulldown assay using the immobilized effector domain of 
Sec5 (Figure 2, A and B). This gain-of-function phenotype was 
specifi c to the loss of RGC2, as knockdown of other GAPs includ-
ing p120 Ras GAP, RapGAP, AS160, or TSC2 had little effect on 
Active RalA
Total RalA
IB: RGC2
IB: pAkt
Insulin
Pulldown
Total Cell Lysate
Co
ntr
ol 
siR
NA
RG
C2
 si
RN
A
A
RalA
RalA + 1X RGC2 IP w/o lysate
RalA + 1X IgG IP
RalA  + 1X RGC2 IP + peptide
RalA + 1X RGC2 IP
RalA + 4X RGC2 IP
RalA + 2X RGC2 IP
IB: RGC2
IP:
1X
 R
GC
2
1X
 R
GC
2 w
/o 
lys
ate
1X
 Ig
G
1X
 R
GC
2 +
 pe
pti
de
2%
 In
pu
t
0
20
180
160
140
120
100
80
60
40
0 10 3020
Time (minutes)
Fr
ee
 γ 
 
 
-
Ph
os
ph
at
e 
(p
mo
le)
32
C
1 
2 
3 
4 
5 
6 
Control RGC2
p = 0.010
p = 0.015
Control
siRNA
RGC2
siRNA
0
Basal
Insulin
B
R
al
A 
A
ct
iv
at
io
n 
(A
.U
.
)
 
Contro GARNL
p = 0.29
p = 0.64
Control
siRNA
GARNL1
siRNA
0
1
2
3
Basal
Insulin
E
R
al
A 
A
ct
iv
at
io
n 
(A
.U
.
)
Total Cell Lysate
Pulldown
Active RalA
Total RalA
IB: GARNL1
IB: RGC2
IB: pAkt
Insulin
Co
ntr
ol 
siR
NA
GA
RN
L1
 si
RN
A
RG
C2
 si
RN
AD
FIGURE 2: RGC2 negatively regulates RalA activity in adipocytes. (A) 3T3-L1 adipocytes were transfected with control 
siRNA or siRNA oligos that deplete RGC2. Four days after transfection, cell lysates were subjected to a pulldown assay 
to detect RalA activation. Pulldowns represent the amount of active RalA from half of a 10-cm plate of adipocytes. 
Lysates represent 2% of total protein from a 10-cm plate of adipocytes. (B) Quantifi cation of RalA activity upon RGC2 
knockdown from three independent experiments. Signifi cance was determined by Student’s t test. (C) E. coli–expressed 
recombinant RalA loaded with γ32-GTP was incubated with increasing amounts of immune complexes from 
immunoprecipitations (IP) with the indicated antibodies (1X = immune complex from half of a 15-cm dish; 2X = immune 
complex from one 15-cm dish; 4X = immune complex from two 15-cm dishes). Free γ32-phosphate was measured as a 
refl ection of GTP hydrolysis. Top: RGC2 proteins present in the IP were determined by WB analysis. (D) 3T3-L1 
adipocytes were transfected with control siRNA, siRNA oligos that deplete GARNL1, or siRNA oligos that deplete 
RGC2. Four days after transfection, cell lysates were subjected to a pulldown assay to detect RalA activation. Pulldowns 
represent the amount of active RalA from half of a 10-cm plate of adipocytes. Lysates represent 2% of total protein from 
a 10-cm plate of adipocytes. (F) Quantifi cation of RalA activity upon GARNL1 or RGC2 knockdown from two indepen-
dent experiments.
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GARNL1 protein levels when cells were transfected with siRNA to 
deplete RGC2 (Figure 2D). Analysis of the expression of GARNL1 
and RGC2 during adipocyte differentiation revealed the up-regu-
lation of GARNL1 protein levels during the clonal expansion stage 
of 3T3-L1 adipogenesis, followed by a marked down-regulation 
during later stages of differentiation, with little GARNL1 protein 
present in mature 3T3-L1 adipocytes (Supplemental Figure S3B). 
In contrast, RGC2 expression was induced during insulin treatment 
of adipocytes and remained high in mature adipocytes (Supple-
mental Figure S4B). Furthermore, RGC2 was the predominant Ral 
GAP expressed in primary white adipocytes (Supplemental Figure 
S4C). Taken together, these data indicate that RGC2 is the primary 
Ral GAP expressed in adipocytes and is responsible for regulating 
RalA activity in these cells. The identifi cation of a specifi c Ral GAP 
in adipocytes points to a novel regulatory process targeting this G 
protein in insulin action.
perhaps due to differences in the assay used to detect activity. 
Immunoprecipitated RGC did not stimulate GTP hydrolysis of 
other GTPases of close homology to Ral, such as Rheb (Supple-
mental Figure S3B) or H-Ras (Supplemental Figure S3C), demon-
strating the specifi city of the GAP activity of the RGC proteins for 
Ral GTPases.
A protein named GARNL1 was recently isolated in complex 
with RalAQ72L and RGC1 in brain lysates (Shirakawa et al., 2009). 
GARNL1 contains a GAP domain with 83% identity to the GAP 
domain of RGC2 (Supplemental Figure S4A) and has in vitro activ-
ity toward Ral GTPases (Shirakawa et al., 2009). SiRNA-mediated 
depletion of GARNL1 did not affect the activity of RalA in 3T3-L1 
adipocytes (Figure 2, D and E), despite effi cient knockdown of 
GARNL1 protein (∼82% knockdown), whereas knockdown of RGC2 
(∼95% knockdown) increased both basal and insulin-stimulated 
RalA activity. Surprisingly, we observed a ∼245% increase in 
Active RalA
Total RalA
IB: RGC1
IB: pAkt
Insulin
Pulldown
Total Cell Lysate
Co
ntr
ol 
siR
NA
RG
C1
 si
RN
A
IB: Actin
A
IB: RGC1
IB: RGC2
IB: Actin
Insulin
Co
ntr
ol 
siR
NA
RG
C1
 si
RN
A
Total Cell Lysate
D
Total Cell Lysate
IP: FLAG
IB: FLAG
IB: HA
IB: HA
FLAG-RGC2
HA-RGC1
E
Active RalA
Total RalA
Total Cell Lysate
Pulldown
IB: HA-RGC1
IB: FLAG-RGC2
HA-RGC1
Ve
cto
r
RG
C2
 w
ild
-ty
pe
RG
C2
 N
/K
F
Total Cell Lysate
IP: FLAG
IB: Sec8
IB: Exo70
IB: FLAG
IB: Exo70
IB: Sec8
FLAG-RalA
Ve
cto
r
RG
C2
 w
ild
-ty
pe
RG
C2
 N
/K
G
Coiled-coil region
GAP
GAP
TSC1
TSC2
RGC1
RGC2
C
          
          
TSC2    : 
RGC2    : 
Rap1GAP : 
          
                                                                            
                                                                            
FERSVQLLDQIPSYDTHKIAVLYVGEGQSNSELAILSNEHGSYRYTEFLTGLGRLIELKDCQPDKVYLGGLDV-CG
LLRELKNLDSRQCRETHKIAVFYIAEGQED-KCSILSNERGSQAYEDFVAGLGWEVDLSTHCG---FMGGLQR-NG
ASRLIVTFDEHVISNNFKFGVIYQKLGQTS-EEELFSTNEESPAFVEFLEFLGQKVKLQDFKG---FRGGLDVTHG
                                                                            
          
          
TSC2    : 
RGC2    : 
Rap1GAP : 
          
                                                                           
                                                                           
EDGQFTYCWHDDIMQAVFHIATLMPTKDVDKHRCDKKRHLGNDFVSIVYNDSGEDFKLGTIKGQFNFVHVIVTPL
STGQTAPYYATSTVEVIFHVSTRMPS-DSDDSLTKKLRHLGNDEVHIVWSEHSRDYRRGIIPTAFGDVSIIIYP-
QTGTESVYCNFRNKEIMFHVSTKLPYTEGDAQQLQRKRHIGNDIVAVVFQDENTPFVPDMIASNFLHAYVVVQAE
                                                                           
Basal
Insulin
R
al
A 
A
ct
iv
ity
 (A
.U
.
)
0
1
2
3
4
5
Control
siRNA
RGC1
siRNA
B
p < 0.05
p < 0.05
FIGURE 3: RGC1 and RGC2/AS250 form a physical and functional complex to inactivate RalA. (A) 3T3-L1 adipocytes 
were transfected with control siRNA or siRNA oligos that deplete RGC1 and were subjected to a pulldown assay to 
detect RalA activity. Pulldowns represent the amount of active RalA from half of a 10-cm plate of adipocytes. Lysates 
represent 2% of total protein from a 10-cm plate of adipocytes. (B) Quantifi cation of RalA activity upon RGC1 
knockdown from three independent experiments. Signifi cance was determined by Student’s t test. (C) ClustalW 
alignment of the RGC2 and TSC2 GAP domains. (D) 3T3-L1 adipocytes were transfected with control siRNA or siRNA 
oligos that deplete RGC1, and 2% of lysates from a 10-cm plate of adipocytes were resolved on SDS–PAGE and 
subjected to WB using the indicated antibodies. (E) COS-1 cells were transfected with the indicated DNA and subjected 
to immunoprecipitations (IP) with anti-FLAG antibody. Immune complexes were resolved on SDS–PAGE and analyzed by 
WB. (F) COS-1 cells were transfected with FLAG-RalA, HA-RGC1, and either wild-type or the N/K mutant FLAG-RGC2 
construct as indicated. Cell lysates were subjected to pulldown assay to detect 
RalA activation. Pulldowns represent the amount of active RalA from half of a 10-cm plate of COS-1 cells. Lysates 
represent 2% of total protein from a 10-cm plate. (G) COS-1 cells were transfected with FLAG-RalA, HA-RGC1, and 
either wild-type or the N/K mutant FLAG-RGC2 constructs as indicated. Cell lysates were subjected to IP with 
FLAG antibody. Immune complexes were resolved on SDS–PAGE, and the interaction between FLAG-RalA and 
endogenous subunits of the exocyst was visualized by WB using the indicated antibodies.
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TSC1/2 (Figure 3), as well as the PI 3-kinase dependence of the 
activation of RalA by insulin, prompted us to investigate whether 
the GAP RGC2 may also be regulated by Akt-dependent phos-
phorylation downstream of PI 3-kinase activity. Previous mass 
spectrometry studies showed that insulin treatment increased the 
phosphorylation of Ser486, Ser696, and Thr715 on RGC2/AS250 
in adipocytes (Gridley et al., 2006), although the protein kinase 
catalyzing these phosphorylation events was not defi ned. To elab-
orate these signaling events, we generated phosphospecifi c anti-
bodies to each of the three sites. Insulin stimulated the phospho-
rylation of all three sites on RGC2 in 3T3-L1 adipocytes, as 
determined by blotting an anti-RGC2 immune complex or total 
cell lysates with the phosphospecifi c antibodies (Figure 4A). Phos-
phorylation of RGC2 in total cell lysates was depleted upon knock-
down of the protein, further demonstrating the specifi city of the 
RGC1 and RGC2 form a physical and functional complex 
to inactivate RalA
The precipitation of both RGC1 and 2 with the RalA-GDP/AlFx affi n-
ity matrix led us to test whether RGC1/2 forms a functional complex 
to inactivate RalA in vivo. We assayed RalA activity after depletion of 
RGC1 from 3T3-L1 adipocytes by siRNA-mediated knockdown. 
While proximal insulin signaling remained unaffected, as determined 
by p-Akt blotting, knockdown of RGC1 led to increased RalA activity 
in both the basal and insulin-stimulated states (Figure 3, A and B), 
indicating that both RGC proteins are required to form a functional 
GAP complex that inactivates RalA. The nature of this complex is 
reminiscent of the Rheb GAP TSC1/2 complex (Inoki et al., 2003; Li 
et al., 2004a), with which RGC1/2 shares a similar overall structure 
(Figure 3C). Furthermore, alignment of the GAP domains revealed 
that RGC2 shares a conserved catalytic asparagine residue with 
TSC2 and RapGAP (Figure 3C), indicating 
a similar catalytic mechanism among 
these GAPs (Li et al., 2004b). Interesting-
ly, siRNA-mediated knockdown of RGC1 
in adipocytes led to decreased levels of 
RGC2 (Figure 3D), suggesting that physi-
cal interaction is required for maximal sta-
bility of the subunits. Consistent with this 
notion, RGC2 protein was stabilized when 
coexpressed with RGC1, which interacts 
with the former protein (Figure 3E), fur-
ther indicating that these proteins form a 
physical complex for stability. 
We tested whether overexpression 
of RGC1/2 could inactivate RalA in vivo 
via its GAP activity. Consistent with the 
in vitro GAP assay, coexpression of 
RGC1 and 2 in cells signifi cantly de-
creased the activity of the G protein, as 
determined by the pulldown assay (Fig-
ure 3F). This inhibitory effect was absent 
in cells expressing RGC1 and RGC2 N/K, 
in which the critical asparagine residue 
for GAP activity was substituted to lysine 
to abolish the catalytic activity (Figure 
3F). Consistent with these data, overex-
pression of wild-type RGC1/2 decreased 
the interaction between wild-type RalA 
and the exocyst subunits Sec8 and 
Exo70, as assayed by coimmunoprecipi-
tation of endogenous exocyst subunits 
(Figure 3G). The RGC2 N/K mutant had 
a minimal effect on the interaction be-
tween wild-type RalA and exocyst sub-
units, likely due to residual GAP activity 
of the mutant (Figure 3G). Taken togeth-
er, these data demonstrate that RGC1 
and RGC2 form a physical and function-
al GAP complex to inactivate RalA and 
prevent its interaction with the exocyst 
in a manner that resembles inactivation 
of Rheb by the TSC1/2 proteins.
RGC2 is an endogenous substrate 
for Akt2 downstream of PI 3-kinase
The similarity between the RGC1/2 
complex and the Rheb GAP complex 
FIGURE 4: Insulin stimulates phosphorylation of RGC2 in adipocytes. (A) Serum-starved 3T3-L1 
adipocytes were mock treated or stimulated with 100 nM insulin for 10 min, and lysates were 
immunoprecipitated using control rabbit IgG or anti-RGC2 antibody. The immune complexes from 
one 10-cm plate and 2% of total cell lysates were resolved on SDS–PAGE and analyzed by WB 
using the indicated antibodies. (B) 3T3-L1 adipocytes were transfected with control siRNA or 
siRNA oligos to deplete RGC2. Serum-starved cells were mock treated or stimulated with 
100 ng/μl insulin for 10 min before lysis; 2% of cell lysates from a 10-cm plate of adipocytes were 
resolved by SDS–PAGE and subjected to WB analysis with the indicated antibodies. (C) Serum-
starved 3T3-L1 adipocytes were mock treated or stimulated with insulin at the indicated doses for 
10 min before lysis; 2% of cell lysates from a 10-cm plate of cells were resolved by SDS–PAGE and 
analyzed by WB with the indicated antibodies. (D) Serum-starved 3T3-L1 adipocytes were mock 
treated or stimulated with 100 ng/μl insulin for the indicated times; 2% of cell lysates from a 10-cm 
plate of cells were resolved by SDS–PAGE and analyzed by WB with the indicated antibodies. 
(E) Epididymal fat pads were excised from a mouse and starved ex vivo in serum-free DMEM for 
30 min before stimulation with 100 nM insulin for the indicated times; 30 μg of protein per 
condition were resolved by SDS–PAGE, and RGC2 phosphorylation was determined by WB.
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To test whether Akt catalyzed the 
phosphorylation of RGC2 on these 
sites, immunoprecipitated RGC1/2 
complex was subjected to an in vitro 
phosphorylation assay in the presence 
of recombinant Akt2. Akt2 directly 
phosphorylated all three sites on RGC2 
(Figure 5A). To ascertain the Akt isoform 
responsible for RGC2 phosphorylation 
in cells, we depleted Akt1, Akt2, or 
both isoforms in adipocytes by siRNA-
mediated knockdown (Figure 5B, top). 
Knockdown of Akt1 produced minimal 
inhibition of Akt signaling, as deter-
mined by blotting with the phospho-
Akt antibody, while knockdown of Akt2 
alone or in combination with Akt1 dra-
matically attenuated Akt activation (Fig-
ure 5B, middle). SiRNA-mediated re-
duction in Akt2 activity led to inhibition 
of RGC2 phosphorylation on all three 
sites (Figure 5B, bottom), supporting 
the notion that the GAP RGC2 is an en-
dogenous substrate of Akt2 in adipo-
cytes. Interestingly, acute inhibition of 
Akt activity by incubation of cells with 
wortmannin blunted insulin-stimulated 
phosphorylation on Ser696 of RGC2, 
while phosphorylation of Ser486 and 
Thr715 was less sensitive, indicating that 
these sites may require lower Akt activity 
for phosphorylation (Figure 5C). Alter-
natively, it remains possible that Ser696 
phosphorylation undergoes more effi -
cient turnover. Collectively, the data 
indicate that activation of Akt2 via the 
PI 3-kinase pathway regulates RGC2 
phosphorylation.
To further test this hypothesis, we 
used an active form of Akt2 in which 
the lipid-binding PH domain is replaced 
with a myristoylation sequence (Myr-
Akt ΔPH). RGC2 phosphorylation was 
readily detectable when expressed in 
293T cells that possess high endoge-
nous Akt activity and was inhibited af-
ter blockade of PI 3-kinase/Akt activity 
by wortmannin, as confi rmed by phos-
pho-Akt blotting (Figure 5D). However, 
although wortmannin blocked signal-
ing events upstream of Akt, inhibition 
of RGC phosphorylation with this compound could be bypassed 
by the expression of Myr-Akt ΔPH, demonstrating that this phos-
phorylation event is catalyzed directly by Akt (Figure 5D). To fur-
ther confi rm that phosphorylation of RGC2 is dependent on Akt 
activity, we also used Akti-1/2, an inhibitor with high specifi city 
for Akt kinases by targeting the PH domain (Lindsley et al., 2005; 
Logie et al., 2007). Treating adipocytes with Akti-1/2 led to 
inhibition of Akt-dependent phosphorylation events, as detect-
ed by phospho-FKHR and phospho-TSC2 WB, whereas Akt-
independent phosphorylation events remained intact, as visual-
ized by phosphotyrosine and phospho-Erk blotting (Figure 5E). 
phospho antibodies (Figure 4B). Insulin stimulated the phosphory-
lation of RGC2 in a dose-dependent manner that correlated well 
with the phosphorylation of Akt (Figure 4C). A time course of insu-
lin treatment of adipocytes revealed that phosphorylation of the 
Ser696 and Thr715 sites was sustained for up to 90 min (Figure 
4D). Phosphorylation at the Ser486 site peaked at 45 min and de-
creased by 90 min, perhaps indicating faster turnover at this site 
(Figure 4D). Consistent with the data from 3T3-L1 adipocytes, in-
sulin also stimulated phosphorylation of RGC2 in white adipose 
tissue for up to 30 min (Figure 4E), providing in vivo evidence for 
this phosphorylation event.
FIGURE 5: RGC2 is an endogenous substrate of Akt2 in adipocytes. (A) COS-1 cells were 
transfected with HA-RGC1 and FLAG-RGC2 constructs as indicated. The RGC proteins were 
isolated by IP with FLAG antibody and subjected to an in vitro kinase assay with 100 ng recombi-
nant Akt2 kinase and 100 μM ATP for 30 min at 32°C. The immune complexes were resolved on 
SDS–PAGE and analyzed by WB using the indicated antibodies. (B) 3T3-L1 adipocytes were 
transfected with control siRNA or siRNA oligos that deplete Akt1, Akt2, or both Akt isoforms. 
Four days after transfection, serum-starved cells were mock treated or stimulated with 100 nM 
insulin for 10 min; 2% of total lysates from a 10-cm plate of 3T3-L1 adipocytes were resolved on 
SDS–PAGE and subjected to WB analysis with the indicated antibodies. (C) Serum-starved 3T3-L1 
adipocytes were pretreated with 100 nM wortmannin (WM) for 1 h before stimulation as in (B); 2% 
of total lysates from a 10-cm plate of 3T3-L1 adipocytes were resolved on SDS–PAGE and analyzed 
by WB using the indicated antibodies. (D) 293T cells were transfected with HA-RGC1, FLAG-RGC2, 
and Myr-Akt ΔPH constructs as indicated. Cells were treated with 100 nM WM for 1 h before lysis. 
RGC2 phosphorylation levels were determined by WB with the RGC2 phospho-715 antibody. (E) 
Serum-starved 3T3-L1 adipocytes were pretreated with 100 μM Akti-1/2 for 2.5 h before mock 
treatment or stimulation with 100 nM insulin for 10 min; 2% of total lysates from a 10-cm plate of 
3T3-L1 adipocytes were resolved by SDS–PAGE and analyzed by WB using the indicated 
antibodies.
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RalA is activated through inhibition of the Ral GAP complex
It has been suggested that the GAP activity of TSC2 and AS160 
against their target G proteins is blocked by Akt-catalyzed phos-
phorylation (Inoki et al., 2002; Manning et al., 2002; Sano et al., 
2003, 2007; Cai et al., 2006), although the molecular mechanism 
Interestingly, treatment of 3T3-L1 adipocytes with Akti-1/2 blunt-
ed insulin-stimulated phosphorylation of RGC2 at Ser486, 
Ser696, and Thr715 (Figure 5E). These data suggest that insulin, 
via activation of Akt2, differentially regulates RGC2 phosphoryla-
tion on different sites.
FIGURE 6: Insulin activates RalA by inhibiting the Ral GAP complex. (A) COS-1 cells were transfected with FLAG-RalA, 
FLAG-RalAF39L, and Myr-Akt-HA as indicated. Cell lysates were subjected to a pulldown assay to detect RalA activa-
tion. Pulldowns represent the amount of active RalA from half of a 10-cm plate of COS-1 cells. Lysates represent 2% of 
total protein from a 10-cm plate. (B) COS-1 cells were transfected with FLAG-RalA, HA-RGC1, FLAG-RGC2, and 
Myr-Akt-HA constructs as indicated. Cell lysates were subjected to a pulldown assay to detect RalA activation. 
Pulldowns represent the amount of active RalA from half of a 10-cm plate of COS-1 cells. Lysates represent 2% of total 
protein from a 10-cm plate. (C) Serum-starved 3T3-L1 adipocytes were pretreated with dimethyl sulfoxide (DMSO) or 
100 μM Akti-1/2 for 2.5 h. Cells were then mock treated or stimulated with 100 nM insulin as indicated. Cell lysates 
were subjected to a pulldown assay to detect RalA activation. Pulldowns represent the amount of active RalA from half 
of a 10-cm plate of 3T3-L1 adipocytes. Lysates represent 2% of total protein from a 10-cm plate. (D) Quantifi cation of 
RalA activation in mock treated and Akti-1/2-treated cells in three independent experiments. Signifi cance was deter-
mined by Student’s t test. (E) Serum-starved 3T3-L1 adipocytes were mock treated or stimulated with 100 nM insulin for 
10 min. Total cell lysates from a 10-cm plate of adipocytes were subjected to immunoprecipitation (IP) with the pan-715 
antibody or the p715 antibody. The immune complexes were then incubated with 0.5 μg E. coli–expressed recombinant 
RalA loaded with γ32-GTP for 10 min. Free γ32-phosphate was measured as a refl ection of GTP hydrolysis. Top: Western 
blot of immune complexes with the indicated antibodies. (F) Serum-starved 3T3-L1 adipocytes were mock treated or 
stimulated with 100 ng/μl of insulin for 10 min. Lysates from a 10-cm plate of cells were subjected to immunoprecipita-
tion with control antibody or RGC1 antibody. The immune complexes were resolved on SDS–PAGE and analyzed by WB 
using the indicated antibodies. The nitrocellulose membrane was stained with Ponceau S dye to verify equal loading. 
(G) 293A cells were transfected with HA-RalAQ72L, HA-RGC1, and FLAG-RGC2 as indicated. Cells were treated with 
DMSO or 100 nM wortmannin for 1 h to decrease active Akt levels, and RGC proteins were immunoprecipitated with 
an anti-FLAG antibody. Immune complexes were resolved by SDS–PAGE and analyzed by WB with the indicated 
antibodies.
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lation led to reduced access of RGC2 GAP to its substrate. Together, 
these data suggest that insulin activates the protein kinase Akt to 
directly phosphorylate the RGC, which produces a conformational 
change in the complex that decreases its access to RalA, resulting in 
increased activity of the G protein.
RGC proteins regulate GLUT4 traffi cking 
in 3T3-L1 adipocytes
Activation of Akt kinases downstream of PI 3-kinase plays an essen-
tial role in insulin-stimulated GLUT4 exocytosis (Whiteman et al., 
2002; Watson and Pessin, 2006), and expression of an activated 
version of the kinase can promote glucose uptake in adipocytes, 
although to an extent less than that seen with insulin (Kohn et al., 
1996; Ng et al., 2008). We and others have reported that the exo-
cyst complex is required for targeting of GLUT4 vesicles to the 
plasma membrane in 3T3-L1 adipocytes (Inoue et al., 2003; Ewart 
et al., 2005), a process that requires activation of RalA in a PI 3-ki-
nase–dependent manner (Chen et al., 2007). This led us to specu-
late that the RGC proteins, which inhibit RalA activity, may function 
as negative regulators of GLUT4 exocytosis. Consistent with this 
idea, Lienhard and colleagues found that adipocytes differentiated 
from fi broblasts stably expressing AS250/RGC2 knockdown shRNA 
displayed increased GLUT4 exocytosis (Gridley et al., 2006). How-
ever, it remains possible that stable knockdown of RGC2 achieved 
in these experiments may have affected the differentiation states of 
adipocytes or led to adaptation of cells to the increased activity of 
Ral GTPases. To avoid these caveats, we acutely depleted RGC1 or 
RGC2 by siRNA-mediated knockdown in mature 3T3-L1 adipo-
cytes. Loss of RGC2 in adipocytes led to a decrease of RGC1 (Fig-
ure 7A), a phenomenon not evident in cells in which RGC2 was 
stably knocked down (Gridley et al., 2006), further implying a po-
tential compensatory process in these cells. Depletion of RGC1 or 
RGC2 in mature adipocytes did not affect proximal signaling events, 
including phosphorylation of insulin receptor, Akt, or Erk, nor were 
there changes in the expression of adipocyte-specifi c proteins such 
as GLUT4 or PPARγ, as determined by WB with the specifi c anti-
bodies (Figure 7A). Knockdown of RGC1 or RGC2 had little effect 
on basal glucose uptake despite an increase in basal RalA activity 
(Figures 2D, 3A, and 7B), perhaps because RalA activation alone is 
not suffi cient for glucose uptake or because the RalA activity ob-
served in an RGC knockdown is not suffi cient to increase basal glu-
cose uptake. However, loss of RGC1 or RGC2 caused an increase in 
glucose uptake after stimulation with submaximal (1 nM) and maxi-
mal (100 nM) insulin concentrations when compared with cells 
transfected with control oligos (Figure 7B). Considering that GLUT1 
transporters also contribute to glucose uptake in cultured adipo-
cytes (Liao et al., 2006), and the fact that siRNA cannot completely 
abolish gene expression, these data suggest that the RGC regu-
lates insulin-stimulated GLUT4 traffi cking in adipocytes. Previous 
studies have shown that knockdown of the Rab GAP AS160 increas-
es basal glucose uptake with little effect on insulin-stimulated glu-
cose transport (Eguez et al., 2005), indicating that AS160 and the 
RGC proteins may engage different mechanisms to regulate GLUT4 
traffi cking.
To examine the effect of RGC knockdown on GLUT4 traffi cking, 
3T3-L1 adipocytes were infected with a lentivirus expressing a Myc-
GLUT4-eGFP construct that allows for quantifi cation of fused GLUT4 
in nonpermeabilized cells. Cells that were transfected with siRNA to 
deplete both RGC1 and RGC2 demonstrated a ∼70–80% knockdown 
of each protein (Figure 7D). Consistent with the glucose uptake data, 
cells that were depleted of RGC1/2 by siRNA exhibited a 25% in-
crease of cells with exofacial Myc staining when stimulated with 1 nM 
responsible remains unknown. We postulated that, like TSC2 
and AS160, Akt might negatively regulate the inhibitory effect of 
RGC proteins on RalA. Consistent with this idea, expression of 
myristoylated, constitutively active Akt (Myr-Akt) produced an 
increase in wild-type RalA activity (Figure 6A). To determine 
whether the stimulation of RalA by Akt occurred through regula-
tion of the GAP, we coexpressed Myr-Akt with RalAF39L, a fast-
exchanging RalA that is activated independently of GEFs but is 
still responsive to GAPs (Figure 6A). Because RalAF39L displays 
high activity, low concentrations of the mutant were expressed 
with Myr-Akt so that the amount of RalA in the pulldown would 
remain within the linear range of the assay. Interestingly, expres-
sion of Myr-Akt activated RalAF39L, suggesting that Akt can acti-
vate RalA by inhibiting its GAPs (Figure 6A). Moreover, coex-
pression of activated Akt with RGC1/2 alleviated the inhibition 
of RalA by the GAP complex (Figure 6B). In addition, inhibition 
of Akt activity by treatment of adipocytes with Akti-1/2 blunted 
RalA activation by insulin (Figure 6, C and D). Taken together, 
these data suggest that the RGC1/2 proteins provide a direct 
link for the activation of the small GTPase RalA by Akt.
Previous investigations of GAPs downstream of Akt such as 
TSC2 or AS160 have suggested that phosphorylation may directly 
inhibit catalytic activity, though there is little data to defi nitively 
evaluate this model. Alternatively, phosphorylation could restrict 
substrate accessibility of the GAP, therefore leading to the activa-
tion of the downstream GTPases. To evaluate whether phosphory-
lation of RGC2 might directly attenuate its GAP activity, we phos-
phorylated the immunoprecipitated protein in vitro by incubating 
with Akt2 kinase and assayed its activity as a GAP for RalA. Akt-
catalyzed phosphorylation produced little change in the GAP activ-
ity of the RGC immune complex toward recombinant RalA 
(Figure S5). Because it was possible that our failure to observe a 
change in GAP activity refl ected a low degree of phosphorylation 
of the complex, we attempted to isolate stoichiometrically phos-
phorylated GAP complex by immunoprecipitation with the phos-
phospecifi c antibody toward the 715 site (p715) on RGC2, with the 
nonphospho antibody generated from the same epitope (pan-715) 
as a control (Figure 6E), followed by assay of GAP activity. RGC2 
isolated from basal or insulin-stimulated adipocytes by the pan-715 
antibody showed little difference in GAP activity, and phosphory-
lated RGC2 purifi ed by the p715 antibody from insulin-stimulated 
adipocytes displayed essentially the same GAP activity, offering 
evidence that phosphorylation may not inhibit RGC2 catalytic 
capacity per se (Figure 6E).
Despite the fact that phosphorylation did not appear to modu-
late the catalytic activity of RGC2 in vitro, we noticed that the recog-
nition of the native protein by the RGC1 antibody was increased in 
cells treated with insulin, as visualized by an increased amount of 
RGC1 in the immunoprecipitates (Figure 6F, top). This was not due 
to an increase in the amount of antibody or lysate that was included 
in the immunoprecipitation reaction (Figure 6F, Ponceau S staining). 
These data suggest that insulin augments exposure of the antigenic 
sequence to the RGC1 antibody, raising the possibility that phos-
phorylation produces a conformational change in the protein com-
plex involving the regulatory subunit. These data prompted us to 
evaluate the interaction between RalA and the phosphorylated 
complex. When expressed in 293T cells with high endogenous Akt 
activity, the RGC had little interaction with RalAQ72L, a mutant ca-
pable of stabilizing GAP interactions (Figure 6G). Treating the cells 
with wortmannin lowered Akt activity and consequently RGC2 phos-
phorylation but increased the amount of RalA in complex with im-
munoprecipitated RGC1/2 (Figure 6G), suggesting that phosphory-
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DISCUSSION
Insulin-stimulated glucose transport is a pivotal physiological pro-
cess that maintains glucose homeostasis (Saltiel and Kahn, 2001; 
Watson et al., 2004) and serves as a model for signaling-regulated 
exocytosis. While it is clear that exocytic traffi cking of GLUT4 vesi-
cles is under the control of several insulin signaling pathways (Huang 
and Czech, 2007), how these signals govern the transport machiner-
ies responsible for GLUT4 vesicle traffi cking remains uncertain (Hou 
and Pessin, 2007). Investigations of several small G proteins, and 
their upstream GAP and GEFs, indicate that these proteins may 
serve as integrators of signaling and traffi cking events (Watson and 
Pessin, 2006; Welsh et al., 2006; Ishikura et al., 2008). One such 
insulin and a trend of increased GLUT4 insertion when stimulated 
with 100 nM insulin (Figure 7, C and E). To quantitatively assess the 
effect of RGC1/2 knockdown on GLUT4 insertion into the plasma 
membrane, the amount of Myc rim staining versus total eGFP fl uores-
cence was determined. Cells depleted of RGC1/2 displayed an in-
crease in Myc rim staining versus total eGFP fl uorescence when stim-
ulated with 1 nM insulin (Figure 7F). Together these data indicate that 
loss of the RGC results in increased plasma membrane GLUT4 levels, 
either by increased exocytosis, decreased endocytosis, or perhaps 
regulating both endo- and exocytosis of the glucose transporter. 
Thus, the RGC is a novel component of the insulin signaling pathway 
that regulates GLUT4 traffi cking and glucose uptake in adipocytes.
FIGURE 7: The Ral GAP complex regulates glucose uptake and GLUT4 traffi cking in adipocytes. (A) 3T3-L1 adipocytes 
were transfected with control siRNA or siRNA to deplete RGC1 or RGC2. After 7 d, cells were serum starved for 6 h and 
then mock treated or stimulated with 100 nM insulin for 15 min; 2% of lysates from a 10-cm dish of cells were subjected 
to WB analysis with the indicated antibodies. (B) 3T3-L1 adipocytes were transfected with control siRNA or siRNA to 
deplete RGC1 or RGC2. Seven days after transfection, adipocytes were serum-starved for 6 h and then stimulated with 
0, 1, 10, or 100 nM insulin for 30 min. [14C]2-Deoxyglucose uptake was measured as described in Materials and 
Methods. The data are a representative replicate of at least fi ve independent experiments. Signifi cance was determined 
by Student’s t test. *p value < 0.02 between control and RGC1 knockdown; **p value < 0.02 between control and RGC2 
knockdown. (C) Three days after transfection with siRNA to deplete RGC proteins, 3T3-L1 adipocytes were infected 
with lentivirus expressing Myc-GLUT4-eGFP. Four days after infection, cells were serum starved for 6 h and then 
stimulated with 0, 1, or 100 nM insulin. The cells were fi xed without permeabilization, stained with anti-Myc antibody, 
and imaged by confocal microscopy. Arrows denote GFP+ cells with Myc rim staining. (D) 3T3-L1 adipocytes were 
transfected with control siRNA or siRNA to deplete both RGC1 and RGC2. Seven days after transfection, total cell 
lysates were subjected to WB analysis with the indicated antibodies. (E) Quantifi cation of Myc rim staining. At least 100 
cells per condition per experiment were counted for anti-Myc rim staining in at least two separate experiments. Error 
bars represent ± SEM. Signifi cance was determined by Student’s t test. *p value < 0.02. (F) Quantifi cation of ratio of 
Myc fl uorescence and GFP fl uorescence. Total eGFP signal or the Myc signal in the outer 15% of the cell was quantifi ed 
using the CellProfi ler program (Broad Institute, Cambridge, MA). At least 100 cells for each condition tested were 
quantifi ed. The experiment shown is representative of two independent experiments. Error bars represent ± SEM. 
Signifi cance was determined by Student’s t test. *p value < 0.02.
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substrate access. Phosphorylation does not render the complex in-
capable of binding to RalA in vitro, as the complex still exhibits cata-
lytic activity in this setting. Perhaps phosphorylation instead induces 
a change in localization of the complex that prevents it from binding 
to RalA. Additional proteins that are recruited to the RGC complex 
upon its phosphorylation may facilitate the process. Further investi-
gations into the precise mechanisms involved in RGC regulation by 
phosphorylation are ongoing.
MATERIALS AND METHODS
DNA constructs
The human RGC1 cDNA and RGC2 cDNA were amplifi ed by poly-
merase chain reaction from total cDNA generated from MCF7 cells. 
RGC1 cDNA was cloned into a pKH3 vector (Chen et al., 2007). 
RGC2 cDNA was cloned into a pEGFP vector (Clontech, Mountain 
View, CA) with the eGFP sequence replaced with a FLAG tag. The 
RGC2 N/K point mutant was introduced by site-directed mutagen-
esis. Automatic DNA sequencing was performed at the University of 
Michigan DNA Sequencing Core (Ann Arbor, MI). The Myr-Akt-HA 
construct was kindly provided by A. Vojteck (University of Michigan). 
All other constructs were described previously (Chen et al., 2007).
Antibodies
Rabbit polyclonal antibodies were generated by Pacifi c Immunolo-
gy (Ramona, CA). The peptide sequences used for immunization of 
rabbits are as follows: RGC1 (aa 1433-1460, RRKRLESDSYSPPH-
VRRK), RGC2 (aa 451-467, AQEDADKLGLSETDSKE), RGC2 pS486 
(aa 476-495 KRSSSWGRTYpSFTSAMSRGC), RGC2 pS696 (aa 687-
704, KGTAVGRSFpSLSWRSHPD), and RGC2 pT715 (aa 707-724, 
EPMRFRSApTTSGAPGVEK). Total immunoglobulin G (IgG) fractions 
were purifi ed from crude serum using a Protein A IgG purifi cation kit 
(Pierce, Rockford, IL). For pan-antibodies, the IgG fractions were pu-
rifi ed using affi nity columns conjugated to protein-specifi c peptides 
as previously described. For phosphospecifi c antibodies, the total 
IgG fraction was fi rst depleted using an affi nity column conjugated 
to a nonphospho form of the antigenic peptide. The fl ow through 
was subjected to affi nity columns conjugated to the phosphopep-
tides of specifi c proteins. Purifi ed antibodies were once more passed 
through the nonphospho peptide columns to deplete the residual 
nonphospho antibodies and ensure the recognition with phospho-
rylated epitope only. Commercially available antibodies are de-
scribed in the Supplemental Material (see the Experimental 
Procedures).
Cell culture, transfections, and inhibitors
COS-1 and 293T cells were maintained as previously described (Liu 
et al., 2005). 3T3-L1 fi broblasts were maintained and differentiated 
into adipocytes as previously described (Liu et al., 2005). COS-1 cells 
were transfected with DNA using FuGENE 6 transfection reagent 
(Roche, Indianapolis, IN), 293T cells were transfected with DNA us-
ing Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad, 
CA), and 3T3-L1 adipocytes were transfected with Stealth siRNA 
(Invitrogen) by electroporation as previously described (Inoue et al., 
2006). SiRNA sequences are listed in the Supplemental Material. 
Cells were treated with 100 nM Wortmannin (Sigma-Aldrich, St. 
Louis, MO) for 2 h or 1 μM Akti-1/2 (Calbiochem, San Diego, CA) 
for 2.5 h before lysis. 
Tissue lysis
Epididymal fat pads were isolated from 3-mo-old male C57BL/6 
mice. Fat pads were cut into four equal-weight pieces and incu-
bated in serum-free DMEM for 30 min at 37°C before stimulation 
pathway is the Akt substrate and Rab GAP AS160/TBC1D4 
(Sakamoto and Holman, 2008). Consistent with its proposed action 
as a GAP that regulates an important G protein (Sano et al., 2003; 
Miinea et al., 2005), knockdown of AS160 results in a small increase 
in basal glucose uptake and GLUT4 plasma membrane localization, 
in a process dependent on its GAP activity (Sano et al., 2007). Al-
though several reports have shown that AS160’s GAP activity regu-
lates Rabs 8, 10, and 14 (Ishikura et al., 2007; Sano et al., 2007, 
2008), further investigation is required to defi ne the mechanism by 
which it controls transport machineries. 
In addition to the target(s) of AS160, data also support the in-
volvement of the small GTPase RalA in insulin-stimulated glucose 
transport (Chen et al., 2007). A pool of RalA resides on GLUT4 vesi-
cles in adipocytes and upon its activation interacts with the exocyst 
complex that directs the exocytic traffi cking of GLUT4 vesicles. 
While RalA was activated by insulin in a PI 3-kinase–dependent 
manner (Chen et al., 2007), the upstream components involved in 
this process were not known. Here we identify and characterize 
RGC1/2, a GAP complex that connects Akt to RalA. RGC1 and 
RGC2 form a physical and functional complex to inactivate RalA in a 
manner dependent on the GAP activity of RGC2. In response to in-
sulin, Akt2 directly phosphorylates RGC proteins; this process may 
lead to a conformational change of the complex that decreases the 
interaction between RGC and RalA. Loss of RGC proteins causes 
increased RalA activity and glucose uptake and increased plasma 
membrane GLUT4 levels in adipocytes. These data support a regu-
latory role of the RalA/exocyst complex in insulin action and more 
broadly highlight a novel pathway that integrates insulin signaling 
with the mobilization of transport machineries for GLUT4 traffi cking. 
During the preparation of this article, Shirakawa et al. (2009) report-
ed the purifi cation of a Ral GAP complex from brain and lung that 
appears identical to the RGC complex described here. Whether 
Ral GAP is subject to similar hormonal regulation by phosphoryla-
tion in other tissues, or by other protein kinases, will be of interest. 
The RGC1/2 complex shares notable similarities with the tumor 
suppressor complex TSC1/2 that also lies downstream of Akt but 
functions as a GAP for the Rheb GTPase (Manning and Cantley, 2003; 
Li et al., 2004b). Both complexes are comprised of a catalytic subunit 
containing a C-terminal GAP domain and a regulatory/targeting sub-
unit that can stabilize its binding partner. While the Rheb GTPase 
primarily activates the mTORC1 pathway responsible for regulation 
of protein synthesis and cell growth (Inoki and Guan, 2006), Ral 
GTPases mobilize the exocyst complex to direct the transport of 
cargo proteins and membranes (Novick and Guo, 2002). Effi cient re-
location of GLUT4 or perhaps other nutrient transporters in various 
cell types could supply energy for protein synthesis and cell growth. 
Thus, the activation of these two G proteins by Akt via structurally 
related GAP complexes suggests a coordinated yet specialized regu-
lation of cellular metabolism that merits further investigation. 
How does Akt precisely regulate the GAP activity of RGC pro-
teins? Our data clearly demonstrate that RGC2 is an endogenous 
substrate of Akt and further that activation of the kinase leads to 
increased activity of RalA. This resembles the scenario in which Akt 
negatively regulates the GAP activity of TSC2 toward the small 
GTPase Rheb, although the exact mechanism underlying this inten-
sively investigated process remains unknown (Huang and Manning, 
2009). The similarities between the RGC1/2 and TSC1/2 proteins 
lead us to speculate that phosphorylation-mediated inhibition of 
GAP activity could be a universal mechanism to increase the activity 
of small GTPases. While the composition of the GAP complex is not 
altered by insulin, our data support a model in which the hormone 
may induce conformational changes in these proteins that prevent 
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SDS–PAGE. Phosphorylated proteins were then visualized by WB 
using the indicated antibodies. 
For GAP assays, GST-RalA (fi nal concentration 3 μM) was loaded 
in 30 μl of load buffer (20 mM Tris, pH 8.0, 5 mM EDTA, 1 mM 
MgCl2, 50 μM cold GTP, 0.1 mg/ml bovine serum albumin [BSA], 
and 5 μCi [γ-32P]GTP) for 20 min at 20°C. Loaded GST-RalA was 
purifi ed from unbound nucleotide using a 0.5-ml Zeba desalt col-
umn (Pierce). Loaded GST-RalA (30 μl) was then added to 270 μl of 
reaction buffer (20 mM Tris, pH 8.0, 2 mM MgCl2, 100 mM NaCl, 
0.01 mg/ml BSA, 4 mM DTT, and 1 mM cold GTP) with or without 
immunoprecipitated RGC2 to start the reaction. Reactions were in-
cubated at 20°C. At the indicated time points, the reaction was ter-
minated by adding 50 μl of the reaction to 750 μl of quench buffer 
(50 mM NaH2PO4, 5% activated charcoal, pH 2.0) on ice. To monitor 
hydrolysis, 300 μl of the quench buffer supernatant was quantifi ed 
by liquid scintillation counting.
[14C]2-deoxyglucose uptake assay and Myc-GLUT4-eGFP 
assay
3T3-L1 adipocytes were transfected with 1.5 nmol of stealth siRNA 
per 150-mm plate of cells. Electroporated cells from a 150-mm plate 
were reseeded into a 12-well dish. Six days after transfection, cells 
were starved in low-glucose DMEM containing 0.5% fetal bovine 
serum (FBS) for 6 h and then subjected to a [14C]2-deoxyglucose 
uptake assay as previously described (Inoue et al., 2006). 
3T3-L1 adipocytes were transfected with 1.5 nmol of stealth 
siRNA per 150-mm plate of cells and then reseeded onto cover slips 
in a 6-well dish. Three days after electroporation, cells were infected 
with lentiviral particles containing Myc-GLUT4-eGFP (Chen et al., 
2007). Four days after infection, cells were starved for 6 h in low-
glucose DMEM containing 0.5% FBS and then stimulated with 
0, 1, or 100 nM insulin for 20 min. Cells were fi xed in 10% Formalin 
for 10 min at room temperature, and then fi xation was stopped with 
100 mM glycine in phosphate-buffered saline (PBS). Cells were 
incubated in blocking buffer (1% chicken egg serum, 1% BSA, 
2% sodium azide in PBS) for 1 h at room temperature before immu-
nostaining with an anti-Myc antibody (1:500 dilution) overnight at 
4°C. Cells were incubated with Alexa-Fluor conjugated goat anti-
mouse secondary antibody (Molecular Probes, Carlsbad, CA) for 1 h 
at room temperature and then mounted on glass slides with 
VectaShield (Vector Laboratories, Burlingame, CA). Confocal images 
were captured on an inverted Olympus confocal microscope and 
processed using FluoView version 5.0 (Olympus, Melville, NY). 
Myc-positive cells were manually counted in a blind experiment.
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